annual retained earnings:
-$1.43B-$463.66M(-47.92%)Summary
- As of today (July 4, 2025), RXRX annual retained earnings is -$1.43 billion, with the most recent change of -$463.66 million (-47.92%) on December 31, 2024.
- During the last 3 years, RXRX annual retained earnings has fallen by -$1.03 billion (-257.75%).
- RXRX annual retained earnings is now -1030.60% below its all-time high of -$126.59 million, reached on December 31, 2019.
Performance
RXRX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$1.63B-$202.41M(-14.14%)Summary
- As of today (July 4, 2025), RXRX quarterly retained earnings is -$1.63 billion, with the most recent change of -$202.41 million (-14.14%) on March 31, 2025.
- Over the past year, RXRX quarterly retained earnings has dropped by -$574.70 million (-54.27%).
- RXRX quarterly retained earnings is now -664.83% below its all-time high of -$213.60 million, reached on December 1, 2020.
Performance
RXRX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RXRX Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.9% | -54.3% |
| 3 y3 years | -257.8% | -258.2% |
| 5 y5 years | -1030.6% | - |
RXRX Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -257.8% | at low | -213.2% | at low |
| 5 y | 5-year | -1030.6% | at low | -664.8% | at low |
| alltime | all time | -1030.6% | at low | -664.8% | at low |
RXRX Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$1.63B(+14.1%) |
| Dec 2024 | -$1.43B(+47.9%) | -$1.43B(+14.3%) |
| Sep 2024 | - | -$1.25B(+8.3%) |
| Jun 2024 | - | -$1.16B(+9.2%) |
| Mar 2024 | - | -$1.06B(+9.4%) |
| Dec 2023 | -$967.62M(+51.3%) | -$967.62M(+10.6%) |
| Sep 2023 | - | -$874.63M(+11.9%) |
| Jun 2023 | - | -$781.61M(+10.9%) |
| Mar 2023 | - | -$704.88M(+10.2%) |
| Dec 2022 | -$639.56M | -$639.56M(+9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$582.06M(+11.6%) |
| Jun 2022 | - | -$521.62M(+14.4%) |
| Mar 2022 | - | -$456.06M(+14.0%) |
| Dec 2021 | -$400.08M(+87.3%) | -$400.08M(+19.4%) |
| Sep 2021 | - | -$335.15M(+16.5%) |
| Jun 2021 | - | -$287.72M(+17.8%) |
| Mar 2021 | - | -$244.32M(+14.4%) |
| Dec 2020 | -$213.60M(+68.7%) | - |
| Dec 2020 | - | -$213.60M |
| Dec 2019 | -$126.59M | - |
FAQ
- What is Recursion Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual retained earnings year-on-year change?
- What is Recursion Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly retained earnings year-on-year change?
What is Recursion Pharmaceuticals annual retained earnings?
The current annual retained earnings of RXRX is -$1.43B
What is the all time high annual retained earnings for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual retained earnings is -$126.59M
What is Recursion Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, RXRX annual retained earnings has changed by -$463.66M (-47.92%)
What is Recursion Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of RXRX is -$1.63B
What is the all time high quarterly retained earnings for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly retained earnings is -$213.60M
What is Recursion Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, RXRX quarterly retained earnings has changed by -$574.70M (-54.27%)